achondroplasia

Motion blurs of people hurrying around an office
Biotech

BioMarin's R&D head hopes pipeline of good ideas won't 'dry out'

Using a two-pronged strategy, BioMarin is doubling down on therapeutic areas it has scored in previously.
Darren Incorvaia Feb 21, 2025 7:00am
Pfizer

Pfizer punts pair of orphan drugs amid rare disease R&D rethink

Jan 31, 2023 9:15am
handshake

BridgeBio’s QED Therapeutics picks up discarded Novartis cancer drug

Jan 30, 2018 11:16am